Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Alopecia Areata

• Efficacy and Safety of Oral Tofacitinib in the Treatment of Alopecia Areata
• Phase III Study of KX-826 With Adult Male Patients With AGA
• A Study to Assess the Efficacy and Safety of HMI-115 in Male Subjects With Androgenetic Alopecia
• Safety and Efficacy of Oral NXC-736 in Adult Participants With Severe Alopecia Areata
• Methotrexate Versus Triamcinilone Acetonide in Treatment of Recalcitrant Alopecia Areata
• Topical Pentoxifylline; Metformin Versus Betamethasone in the Treatment of Alopecia Areata.
• Hair Regeneration in Androgenetic Alopecia
• A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of IMG-007 in Adult Alopecia Areata Participants
• Randomized, Double-Blind, Placebo-Controlled Phase 2a, Proof-of-Concept Trial of ADX-914 Phase 2a Trial for the Treatment of Severe Alopecia Areata
• A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata
• Effectiveness of Combination Therapy of Microneedling and Minoxidil in Androgenetic Alopecia of Indonesian Men
• Evaluation of the Effect of Topical Calcipotriol Versus Platelet-Rich Plasma
• A Study to Evaluate the Efficacy and Safety of Clascoterone Solution in Treatment of Male Pattern Hair Loss
• Evaluation of Efficacy and Safety of Oral Minoxidil 1 mg in Female Androgenetic Alopecia
• Comparative Efficacy of Tacrolimus and Clobetasol Propionate in Alopecia Areata
• Dupilumab in the Treatment of Pediatric Alopecia Areata
• Investigate the Efficacy and Safety of Farudodstat Compared With Its Placebo in Adult Alopecia Areata Participants
• Phase I Study of Safety and Pharmacokinetics of Topical Solution in Subjects With Androgenetic Alopecia
• A Clinical Observation of 1565nm Non-ablative Fractional Laser in the Treatment of Androgenic Alopecia
• Study of TDM-105795 Following Topical Administration in Male Subjects With Androgenetic Alopecia
• A Study of Oral Minoxidil to Treat Hair Loss in Children, Teens, and Young Adults Who Are Cancer Survivors
• A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata
• A Phase 2 Study to Evaluate the Safety and Efficacy of CKD-498 in Female Patients With Androgenetic Alopecia
• A Study to Learn About the Study Medicine (Called Ritlecitinib) For the Potential Treatment of Severe Alopecia Areata (AA) In Children 6 To Less Than 12 Years of Age
• Safety and Efficacy Study of Topical DLQ01 in the Treatment of Androgenetic Alopecia (AGA) in Men
• Study to Evaluate Safety & Usability of a New Formulation for Male Androgenetic Alopecia
• Combined CO2 Fractional Laser With Bimatoprost 0.03% Treatment of Alopecia Areata
• Exploratory Clinical Trial of Safety and Efficacy of Daily Application of Topical Dutasteride in Men With Androgenic Alopecia.
• New Treatment of Alopecia Areata
• Study of EQ101 in Adult Subjects With Moderate to Severe Alopecia Areata
• Role of Minoxidil in Alopecia Areata Transepidermal Drug Delivery of Minoxidil Via Either Fractional Carbon Dioxide Laser or Microneedling Versus Its Topical Nanoparticles Preparation for Treatment of Alopecia Areata
• A Study to Evaluate Efficacy and Safety of Deucravacitinib in Participants With Alopecia Areata
• Regeneron AA Multicenter (Dupilumab)
• Ritlecitinib for Cicatricial Alopecia
• Combined Microneedling and Topical Pentoxifylline Vesrus Intalesional Pentoxifylline in Treatment of Alopecia Areata: Intra-indiviual Comparative Study
• A Study of KL130008 in Adults With Severe Alopecia Areata
• A Phase 3 Study to Evaluate the Efficacy and Safety of SHR0302 in Adult Patients With Severe Alopecia Areata
• Use of Botulinum Toxin in the Treatment of Androgenic Alopecia
• Topical or Oral Minoxidil for the Treatment of Endocrine Therapy-Induced Alopecia in Patients With Stage I-IV Breast Cancer
• A Pilot Study of Azelaic Acid as a Novel Treatment for Central Centrifugal Cicatricial Alopecia (CCCA)
• A Pilot Study of Calcipotriol as a Novel Treatment for Central Centrifugal Cicatricial Alopecia (CCCA)
• Study Evaluating Efficacy of Topical Squaric Acid Dibutyl Ester in Children and Adolescents With Alopecia Areata
• Evaluate the Efficacy and Safety of Ruxolitinib on Hair Regrowth in Patients With Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (APECED) Associated Alopecia Areata
• Comparison Between Efficacy of Topical Sildenafil 2% and Topical Minoxidil 5% in Treatment of Androgenic Alopecia
• A Trial to Assess the Effect of Delgocitinib Cream 20 mg/g on the Molecular Signature, Safety, and Efficacy in Adults With Frontal Fibrosing Alopecia
• To Evaluate the Safety, Tolerability and Efficacy in Male and Female With AGA Treated With HMI-115 Over a 24-week Treatment Period
• Extension Study to Evaluate Safety and Efficacy of Jaktinib in Adults With Alopecia Areata
• Comparative Study Efficacy and Safety of of Activated Versus Non-Activated PRP
• A Study of TDM-105795 in Male Subjects With Androgenetic Alopecia (AGA)
• To Evaluate Efficacy, Safety, and Tolerability of KX-826 in Male Subjects With Androgenetic Alopecia
• A Study to Evaluate the Safety of MAX-40070 in Healthy Subjects
• Dual JAK1/TYK2 Inhibitor for Cicatricial Alopecia
• Study to Evaluate Safety and Efficacy of Jaktinib in Adults With Alopecia Areata
• European Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata
• Sodium Valproate-loaded Nanospanlastics in Patchy Alopecia Areata in Comparison to Topical Steroids
• Scalp Cooling in MBC
• Safety, Tolerability and Pharmacokinetics of KX826 in Healthy Male Subjects With Androgenetic Alopecia Following Topical Single Ascending Dose Administration
• Efficacy of Jessener Solution Versus Intralesional Steroid in Treatment of Alopecia Areata
• A Phase 1 Study of TDM-105795 Topical Solution in Male Subjects With Androgenetic Alopecia (AGA)
• BL3000 Compared to Pantogar® in the Treatment of Telogen Effluvium in Women.
• Androgenetic Alopecia Treatment Using Varin and Cannabidiol Rich Topical Hemp Oil: A Case Series
• A Study to Evaluate the Efficacy and Safety of AD-208
• A Phase 3 Study to Evaluate the Efficacy and Safety of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areata (THRIVE-AA2)
• A Phase 2 Durability of Response Study of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areata
• A Phase 2a Trial of FOL-005 Topical Formulations to Investigate Hair Growth Potential and Safety in Healthy Male Volunteers
• A Study of JNJ-64304500 in Participants With Alopecia Areata
• Treatment of Androgenetic Alopecia in Men for 24 Weeks
• Intralesional Vitamin D in Alopecia Areata
• Efficacy and Safety of Finlândia Hair Lotion Association on Androgenetic Alopecia
• Safety and Efficacy of Oral Etrasimod in Adult Participants With Moderate-to-Severe Alopecia Areata
• Keratinocyte Growth Factor- Hair Serum for the Prevention of Chemotherapy Induced Alopecia
• A Phase 3 Study to Evaluate the Efficacy and Safety of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areata (THRIVE-AA1)
• PLACEBO-CONTROLLED SAFETY STUDY OF RITLECITINIB (PF-06651600) IN ADULTS WITH ALOPECIA AREATA
• the Safety, Tolerability and PK of KX-826 in Healthy Males With Alopecia Following Topical Multiple Dose Ascending
• Topical Cetirizine in Androgenetic Alopecia in Females
• A Study With Jaktinib Hydrochloride Cream Applied Topically to Subjects With Alopecia Areata
• Modified SALT Score for Alopecia Areata
• Oral Low-Dose Naltrexone for Lichen Planopilaris and Frontal Fibrosing Alopecia
• A Phase II Study in Patients With Alopecia Areata
• Topical Crisaborole in Patients With Alopecia Areata
• Topical Cetirizine 1% vs Minoxidil 5% Gel in Treatment of Androgenetic Alopecia
• Tofacitinib for Immune Skin Conditions in Down Syndrome
• Clinical Trial to Evaluate the Efficacy of Fecal Microbiota Transplantation in Patients With Alopecia Areata
• Comparative Study for Treatment of Alopecia Areata Using Carboxytherapy and Intralesional Steroids
• N-Acetyl-Cysteine for Treatment of AGA in Men
• Treatment Results for Patients With Central Centrifugal Cicatricial Alopecia (CCCA): a Multicenter Prospective Study
• Comparison of Topical Minoxidil 5% in Ethanol Plus Propylene Glycol Versus Minoxidil 5% in Ethanol Alone in Treatment of Women With Female Pattern Hair Loss
• Study to Evaluate the Safety and Efficacy ofJaktinib Hydrochloride Tablets in Severe Alopecia Areata
• Long-Term PF-06651600 for the Treatment of Alopecia Areata
• Efficacy of Fractional CO2 Laser as a Mono- or Adjuvant Therapy for Alopecia Areata
• Efficacy and Tolerability Study of Two Dosing Regimens of CTP-543 in Adults With Alopecia Areata
• A Study of Baricitinib (LY3009104) in Adults With Severe or Very Severe Alopecia Areata
• Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata
• Laser Assisted Delivery of Minoxidil in Androgenetic Alopecia
• Topical Calcipotriol Versus Narrowband Ultraviolet B in Treatment of Alopecia Areata
• Effect of Low-Dose Oral Minoxidil as Treatment of Permanent Chemotherapy-Induced Alopecia
• Efficacy and Tolerability Study of Two Dose Regimens of CTP-543 in Adults With Alopecia Areata
• Effectiveness and Safety of Tofacitinib in Patients With Extensive and Recalcitrant Alopecia Areata
• ATI-502 Topical Solution for the Treatment of Alopecia Areata (AA), Alopecia Universalis (AU) and Alopecia Totalis (AT)
• Evaluating the Topical Herbal Solution on the Treatment of Male Pattern Hair Loss and Comparison With Minoxidil 5%
• A Study Evaluating the Efficacy and Safety of SM04554 Topical Solution in Male Subjects With Androgenetic Alopecia
• PF-06651600 for the Treatment of Alopecia Areata
• The Effect of Platelet Rich Plasma on Non-scarring Alopecia
• DPCP for the Treatment of Alopecia Areata
• Pain Outcomes Following Intralesional Corticosteroid Injections
• ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
• A Study of Baricitinib (LY3009104) in Participants With Severe or Very Severe Alopecia Areata
• Open Label Study of ATI-50002 Topical Solution Administered to Adult Subjects With Eyebrow Loss Due to Alopecia Areata
• Topical 5% Minoxidil and Potent Topical Corticosteroid Versus Intralesional Corticosteroid in the Treatment of Alopecia Areata
• Phase 2 Trial of BNZ-1 in Patients With Moderate to Severe Alopecia Areata
• Apremilast in the Treatment of Central Centrifugal Cicatricial Alopecia (CCCA)
• A Study in Male and Female Subjects With Androgenetic Alopecia Treated With ATI-50002 Topical Solution
• Study to Determine Effect of Gentle Wounding to Stimulate Hair Follicle Neogenesis
• Platelet Rich Plasma Versus Minoxidil Foam for Treatment of Androgenic Alopecia in Women
• Cryotherapy Versus Steroids In Alopecia Areata:Trichoscopic Evaluation
• Trial Evaluating the Efficacy of Apremilast for the Treatment of Frontal Fibrosing Alopecia
• Treatment of Alopecia Areata (AA) With Dupilumab in Patients With and Without Atopic Dermatitis (AD)
• A Study of ATI-50002 Topical Solution for the Treatment of Alopecia Areata
• ENERGI-F701 for Female Hair Loss Treatment
• Role of Neurogenic Inflammation and Topical 6% Gabapentin Therapy in Symptomatic Scarring Alopecia
• Efficacy of Twice Daily Application of LEO 124249 Ointment 30 mg/g for 12 Weeks on Eyebrow Alopecia Areata.
• Safety and Pharmacokinetic Study of ATI-50002 in Subjects With Alopecia Universalis (AU) and Alopecia Totalis (AT)
• Efficacy and Safety of LH-8 in Paediatric Alopecia Areata
• Study to Evaluate the Safety and Efficacy of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areata
• The Effect of Platelet-rich Plasma in Subjects With Androgenetic Alopecia
• Study to Evaluate the Efficacy and Safety of P-3074 Topical Solution in the Treatment of Androgenetic Alopecia
• Study To Evaluate The Efficacy And Safety Profile Of PF-06651600 And PF-06700841 In Subjects With Alopecia Areata
• Efficacy, Safety and Tolerability of CG428 Cutaneous Solution on Chemotherapy Induced Alopecia; Controlled Study (ELAN)
• Adipose Tissue Derived Stem Cell Based Hair Restoration Therapy for Androgenetic Alopecia
• Local Pharmacokinetics and Tolerability of Bimatoprost Applied to the Scalp of Male Patients With Androgenetic Alopecia
• Pharmacokinetics/ Pharmacodynamics and Safety of DA-4001 in Healthy Male Subjects With Androgenic Alopecia
• Topical Tofacitinib for the Treatment of Alopecia Areata and Its Variants
• Photosensitization Study in Androgenetic Alopecia
• A Safety and Efficacy Study of Setipiprant Tablets in Androgenetic Alopecia in Males
• Topical Garlic Concentrate for Alopecia Areata in Children
• Pilot Study of the Safety and Efficacy of Apremilast in Subjects With Moderate to Severe Alopecia Areata
• A Pilot Study of Tralokinumab in Subjects With Moderate to Severe Alopecia Areata
• Safety, Tolerability, and Pharmacokinetics of Bimatoprost in Men With Androgenetic Alopecia (AGA)
• Safety and Efficacy Study of SHAPE Gel in Alopecia Areata
• A Study of Secukinumab for the Treatment of Alopecia Areata
• LEO 124249 Ointment in the Treatment of Alopecia Areata
• TREg Activation in the Treatment of the PELADE (Alopecia Areata)
• A Study With Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata (AA)
• A Study of SM04554 Applied Topically to the Scalp of Male Subjects With Androgenetic Alopecia Analyzed by Biopsy of the Scalp Prior To and Post Dosing
• Minoxidil Dose Response Study in Females Identified Through IVD Testing as Non-Responders to 5% Topical Minoxidil
• The Use of 5mg Finasteride Versus 200mg Spironolactone and Topical 5% Minoxidil in Treating Postmenopausal Female Androgenetic Alopecia
• Minoxidil 2% Solution and Botanical Hair Regimen in Women With Thinning Hair and Female Pattern Hair Loss/Androgenic Alopecia
• Minoxidil 5% / Botanical Hair Regimen in Men With Thinning Hair and Male Pattern Hair Loss/Androgenic Alopecia
• Comparison of Topical Latanoprost vs Topical Corticosteroid in Treatment of Localized Alopecia Areata
• Tofacitinib for the Treatment of Alopecia Areata and Its Variants
• Study To Evaluate The Efficacy Of Tofacitinib In Moderate To Severe Alopecia Areata, Totalis And Universalis
• Clinical Trial to Explore the Efficacy and Safety of DA-4001 After Topical Application
• A Phase 2 Study to Evaluate the Safety and Efficacy of CB-03-01 Solution, a Comparator Solution and Vehicle Solution in Males With Androgenetic Alopecia
• A Study of the Safety, Tolerability, and Efficacy of Topical SM04554 Solution in Male Subjects With Androgenetic Alopecia (AGA)
• Minoxidil Response Testing in Females With Female Pattern Hair Loss
• Minoxidil Response Testing in Males With Androgenetic Alopecia
• Tofacitnib for the Treatment of Alopecia Areata and Variants
• Topical Bimatoprost Effect on Androgen Dependent Hair Follicles
• The Efficiency Of The Methotrexate At Patients Affected By Grave Pelade
• An Open-Label Single-Arm Clinical Trial to Evaluate The Efficacy of Abatacept in Moderate to Severe Patch Type Alopecia Areata
• Sexual Function in Men Receiving Dutasteride for Androgenetic Alopecia
• Pilot Study to Evaluate the Efficacy of Ruxolitinib in Alopecia Areata
• Bioequivalence Study of Dutasteride Five 0.1 mg and One 0.5 mg Soft Gelatin Capsules in Healthy Male Volunteers
• A Clinical Trial to Evaluate the Efficacy of Abatacept in Moderate to Severe Alopecia Areata
• A Safety and Efficacy Study of Bimatoprost in Men With Androgenic Alopecia (AGA)
• A Study to Evaluate the Superiority, Efficacy and Tolerability of Combination Pantovigar With 2% Minoxidil vs 2% Minoxidil in Women With Female Pattern Hair Loss
• Intralesional Steroids in the Treatment of Alopecia Areata
• Evaluation of the Efficacy and Tolerability of Treatment With Interleukin-2 in Severe and Resistant Alopecia Areata
• A Long-term Study to Determine Safety and Efficacy of Dutasteride in Male Subjects With Androgenetic Alopecia
• Combined Restylane and Triamcinolone Acetonide Injections for the Treatment of Alopecia Areata
• The Efficacy in Treatment of Female Pattern Hair Loss Using 5% Minoxidil Solution Combinded With Zinc Supplement
• Efficacy and Safety of Mesotherapy With Minoxidil 0.5%/2ml for Androgenetic Alopecia in Female Patients
• Phototoxic Doses of Ultraviolet A for Treatment of Alopecia Areata
• Vytorin in the Treatment of Alopecia Areata
• A Trial of Clobetasol Propionate Versus Hydrocortisone in Children With Alopecia Areata
• Efficacy Study of Minoxidil Lotion Versus Combined Minoxidil and Finasteride Lotion to Treat Male Pattern Hair Loss
• Exploratory Study of Norepinephrine to Prevent Alopecia in Head and Neck Cancer Patients Treated With Radiotherapy
• Safety and Efficacy Study of Bimatoprost in the Treatment of Men With Androgenic Alopecia
• Effectiveness and Safety of Minoxidil Foam Versus Placebo Foam for Androgenetic Alopecia
• Abatacept Costimulatory Blockade in the Treatment of Alopecia Totalis/Universalis
• Microarray Analysis of Scalp Biopsies After Minoxidil Treatment
• The Efficacy and Safety of Different Concentrations of Localized Injections of Steroids in the Treatment of Alopecia Areata
• Dutasteride Versus Placebo and Finasteride in Men With Androgenetic Alopecia
• Clinical Trial in Females for Female Pattern Hair Loss
• Safety and Pharmacokinetics Study of New Formulation of Bimatoprost in Patients With Alopecia
• Safety and Efficacy of Oral Mega Pulse Methylprednisolone in Severe Therapy Resistant Alopecia Areata
• Clinical Trial in Females With Female Pattern Hair Loss
• Safety and Efficacy of Clobetasol Propionate 0.05% E Foam in Alopecia
• Association of Polymorphisms in the Androgen Receptor Gene and Finasteride Response in Women With Androgenetic Alopecia
• Safety and Efficacy of Bimatoprost Solution in Treating Eyelash Loss or Hypotrichosis in Children
• AVODART® Alopecia Post-marketing Surveillance (PMS)
• The Comparison Study of Intralesional Botulinum Toxin A and Corticosteroid Injection for Alopecia Areata
• Bimatoprost Ophthalmic Solution in Increasing Eyebrow and Eyelash Growth in Patients Who Have Undergone Chemotherapy for Breast Cancer and in Healthy Participants
• The Randomized Double-blind Placebo-controlled Trial of Intralesional Botulinum Toxin A Injection for Recalcitrant Alopecia Totalis and Alopecia Universalis
• Treatment of Male Pattern Baldness With Botulinum Toxin
• Efficacy and Safety Study to Compare Two Minoxidil Formulations on Women With Androgenetic Alopecia
• Efficacy Study of Tempol to Prevent Hair Loss From Radiotherapy to the Brain
• Efalizumab in the Treatment of Alopecia, Phase II
• Safety and Preliminary Efficacy Study of MTS-01 for the Prevention of Alopecia Induced by WHole Brain Radiotherapy
• Adrenal Function and Use of Intralesional Triamcinolone Acetonide 10 mg/mL (Kenalog-10) in Patients With Alopecia Areata
• Dose-Ranging Efficacy Study of Topical NEOSH101 to Treat Male Pattern Hair Loss
• A Study To Assess The Efficacy And Safety Of Dutasteride 0.5mg Once Daily For 6 Months In The Treatment Of Male Subjects With Androgenetic Alopecia
• Efficacy Study of Topical NEOSH101 to Treat Male Pattern Hair Loss
• Topical AS101 for Treatment of FAGA (Female Androgenetic Alopecia) in Menopause Women
• Treatment of Alopecia Areata of the Scalp With Intradermal Injections of Botulinum Toxin
• Effects of Finasteride on Serum Prostate-Specific Antigen (0906-111)
• The Effect of 0.5% Roxithromycin Lotion for Androgenetic Alopecia
• Efficacy Study of Latanoprost and Bimatoprost Solutions in Promoting Eyelash Growth in Patients With Alopecia Areata
• Aldara for the Treatment of Extensive Alopecia Areata
• Plaquenil for Alopecia Areata, Alopecia Totalis
• Response of Topical Capsaicin in Alopecia Areata
• Characteristics of T Cells From Alopecia Areata Scalp Skin Before and After Treatment With Aldara 5%
• Efficacy of Therapy With the Spironolactone Pills Compared to Minoxidil Lotion in Female Pattern Hair Loss
• Alefacept in Patients With Severe Scalp Alopecia Areata
• A Study to Evaluate the Effectiveness and Safety of 5 Percent Minoxidil Foam in the Treatment of Male Pattern Hair Loss
• Phase II Randomized Bilateral Comparison of Topical Targretin Gel 1% in Alopecia Areata